Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea

• Main Authors: Won Suk Choi (Author), Ji Yun Noh (Author), Jacob Lee (Author), Jun Yong Choi (Author), Jin-Soo Lee (Author), Moo Soo Kim (Author), Hee Soo Kim (Author), Joon Bang (Author), Nathalie Lavis (Author), Woo Joo Kim (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

VaxigripTetra® (Sanofi Pasteur, Lyon, France) is a quadrivalent split-virion inactivated influenza vaccine (IIV4) containing two B-lineage strains approved in the European Union and Taiwan in 2016 for individuals ≥ 3 years of age. Here, we describe an observer-blind, randomized, controlled, multicen...